NCT04897438View on ClinicalTrials.gov

Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

July 18, 2023

Study Completion Date

September 9, 2024

Conditions
Kidney Transplant RejectionAntibody-mediated RejectionKidney Transplant Failure
Interventions
PROCEDURE

Kidney allograft biopsy depending on donor-derived cell-free DNA levels

Kidney allograft biopsy is performed, when absolute levels of donor-derived cell-free DNA are above 50 copies/ml

Trial Locations (1)

10117

Charité-Universitätsmedizin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER